<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01214070</url>
  </required_header>
  <id_info>
    <org_study_id>C6687-R</org_study_id>
    <nct_id>NCT01214070</nct_id>
  </id_info>
  <brief_title>Functional Vision in TBI</brief_title>
  <official_title>Functional Vision Consequences of Rehabilitation for TBI Vision Loss</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to test functional vision outcome measures that reflect the
      loss in everyday life tasks that require vision and that are sensitive to changes after a
      course of vision rehabilitation in Veterans/participants with TBI.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Traumatic brain injury (TBI) can cause vision loss because of diffuse or focal neuronal
      injury. Vision can be compromised because of local injury to one or both optic nerves,
      diffuse brain injury, and/or limitation in eye movements because of dysfunction of cranial
      nerves. These typical injuries may compromise any of the neural pathways that subserve
      afferent or efferent visual function. Self-reports of vision loss include diplopia, visual
      field loss, light sensitivity, reading problems and contrast sensitivity (color and
      luminance) loss. This project will pursue the following aims: 1) Identify the relationship
      between functional vision loss in everyday vision tasks (reading, visual search, way finding)
      and the characteristics of potential visual impairment (visual acuity, contrast sensitivity,
      visual fields, stereoacuity, eye movement disorders) associated with TBI; and 2) Determine
      the ability of the vision rehabilitation interventions (both monotherapy and combination
      therapy) to improve functional vision outcome measures that reflect everyday visual tasks.
      The vision rehabilitation interventions incorporated into this study will be Vision
      Restoration Therapy, NVT Eye Scanning Therapy, and standard Eccentric Viewing Training. These
      therapies are rehabilitative interventions prescribed for Veterans in Polytrauma
      Rehabilitation Centers, Blind Rehabilitation Centers, and advocated for VA Medical Center TBI
      clinics.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Administrative Closure
  </why_stopped>
  <start_date type="Actual">June 1, 2012</start_date>
  <completion_date type="Actual">November 21, 2013</completion_date>
  <primary_completion_date type="Actual">November 21, 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dynamic Visual Field</measure>
    <time_frame>Baseline</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Dynamic Visual Field</measure>
    <time_frame>After First Therapy / Before Second Therapy (Average time is 4.5 months)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dynamic Visual Field</measure>
    <time_frame>After Second Therapy (Average Time is 9 months)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reading Rate and Accuracy</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reading Rate</measure>
    <time_frame>After First Therapy / Before Second Therapy (average time is 4.5 months)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reading Rate and Accuracy</measure>
    <time_frame>After Second Therapy (average time is 9 months)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Search Accuracy and Timing</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Search Accuracy and Timing</measure>
    <time_frame>After First Therapy / Before Second Therapy (average time is 4.5 months)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Search Accuracy and Timing</measure>
    <time_frame>After Second Therapy (average time is 9 months)</time_frame>
  </secondary_outcome>
  <number_of_arms>7</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Brain Injuries</condition>
  <condition>Visually Impaired Persons</condition>
  <arm_group>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group 1 - Combination Treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group 2 - Combination Treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group 3 - Combination Treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 4</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group 4 - Combination Treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 5</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group 5 - Monotherapy Treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 6</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group 6 - Monotherapy Treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 7</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group 7 - Monotherapy Treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Vision Restoration Therapy</intervention_name>
    <description>Therapy that enhances the neuronal plasticity of the visual system</description>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_label>Arm 3</arm_group_label>
    <arm_group_label>Arm 5</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>NVT Eye Scanning Therapy</intervention_name>
    <description>Therapy that trains eye and head scanning into the blind hemianoptic visual field</description>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_label>Arm 3</arm_group_label>
    <arm_group_label>Arm 7</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Eccentric Viewing Training</intervention_name>
    <description>Therapy that trains the person to compensate for visual field loss by learning to move the visual field loss to the position that is least likely to impact the current visual task</description>
    <arm_group_label>Arm 2</arm_group_label>
    <arm_group_label>Arm 4</arm_group_label>
    <arm_group_label>Arm 6</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Sham</intervention_name>
    <description>Therapy that encourages subjects to do daily visual tasks at home while having no training or intended intervention benefit</description>
    <arm_group_label>Arm 5</arm_group_label>
    <arm_group_label>Arm 6</arm_group_label>
    <arm_group_label>Arm 7</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  TBI (any form)

          -  Hemianopic Visual Field Loss

          -  Stable fixation

          -  1.0 logMAR or better Reading Acuity

          -  20 words per minute or better reading rate

        Exclusion Criteria:

          -  Visual Neglect

          -  medical conditions that prevent sitting for 30 minutes or following instructions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ron Schuchard, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Palo Alto Health Care System</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA Palo Alto Health Care System</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304-1290</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2010</study_first_submitted>
  <study_first_submitted_qc>September 30, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 4, 2010</study_first_posted>
  <last_update_submitted>June 14, 2017</last_update_submitted>
  <last_update_submitted_qc>June 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Visual Perception</keyword>
  <keyword>Vision, Ocular</keyword>
  <keyword>Neuronal Plasticity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

